Abbott (ABT) Q3 2022 earnings call
Abbott (NYSE: ABT) Q3 2022 Earnings Conference
Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — Chairman and…
Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers
Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%.…
Abbott (ABT) Q2 2022 Earnings conference
Abbott (NYSE: ABT) Q2 2022 Earnings Conference
ADVERTISEMENT
Market News
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment registering strong sales…
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations Robert B. Ford — Chairman and Chief Executive…
AlphaGraphs
Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first quarter were $2.4…
Abbott Laboratories (ABT) Q1 2022 Earnings Call
Abbott Laboratories (NYSE: ABT) Q1 2022 Earnings Conference
ADVERTISEMENT
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing & Acquisitions Robert B. Ford — Chairman…
Abbott Laboratories (ABT) Q4 2021 earnings conference call
Abbott Laboratories (NYSE: ABT) Q4 2021 Earnings Conference